N/A
Completed N=72
Treatment of Androgenetic Alopecia in Females, 9 Beam
androgenetic alopecia · Hair Loss · Female Pattern Baldness
Source: ClinicalTrials.gov NCT00981461 ↗
Enrolled (actual)
72
Serious AEs
0.0%
Results posted
Jul 2012
Primary outcomePrimary: Changes in Terminal Hair Count Week 16 and 26 Weeks Over Baseline — 1.3; 14.8; 2.8; 20.2 hairs per cm^2
Summary
The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 9 beam model in promoting hair growth in females diagnosed with androgenetic alopecia when treatment is applied as directed.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Changes in Terminal Hair Count Week 16 and 26 Weeks Over Baseline |
1.3; 14.8; 2.8; 20.2 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosis of androgenetic alopecia
- Fitzpatrick Skin Types I-IV
- Ludwig I-4, II-1, II-2, or frontal
- Active hair loss within last 12 months
Exclusion Criteria
- Photosensitivity to laser light
- Malignancy in the target area
- Pregnancy
- Lactating females
Data sourced from ClinicalTrials.gov (NCT00981461). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.